BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24164387)

  • 21. Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system.
    Fülöp T; Larbi A; Dupuis G; Pawelec G
    Arthritis Res Ther; 2003; 5(6):290-302. PubMed ID: 14680505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte traffic control by chemokines.
    Moser B; Loetscher P
    Nat Immunol; 2001 Feb; 2(2):123-8. PubMed ID: 11175804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases.
    Kwon B; Kim BS; Cho HR; Park JE; Kwon BS
    Exp Mol Med; 2003 Feb; 35(1):8-16. PubMed ID: 12642898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction to Lymphocyte Trafficking in Disease.
    Lalor PF; Hepburn EA
    Methods Mol Biol; 2017; 1591():169-176. PubMed ID: 28349482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell positioning by chemokines in autoimmune skin diseases.
    Richmond JM; Strassner JP; Essien KI; Harris JE
    Immunol Rev; 2019 May; 289(1):186-204. PubMed ID: 30977191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine control of lymphocyte trafficking: a general overview.
    Stein JV; Nombela-Arrieta C
    Immunology; 2005 Sep; 116(1):1-12. PubMed ID: 16108812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokines and proteinases in autoimmune diseases and cancer.
    Opdenakker G; Van Damme J
    Verh K Acad Geneeskd Belg; 2002; 64(2):105-36. PubMed ID: 12085566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of T-lymphocytes in organ-specific autoimmune diseases].
    Fierz W
    Schweiz Med Wochenschr; 1987 Mar; 117(11):391-8. PubMed ID: 3495035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
    Roep BO
    Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines and lymphocytes: the role of chemokines and their receptors in the immune system.
    Hasegawa H; Fujita S
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):599-607. PubMed ID: 11502068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic progress towards the molecular basis of common autoimmunity.
    Merriman TR; Pearce SH
    Discov Med; 2006 Feb; 6(31):40-5. PubMed ID: 17234127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
    Alt C; Laschinger M; Engelhardt B
    Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of lymphocyte apoptosis as a strategy for preventing and treating autoimmune disorders: a role for whole-food vegan diets, fish oil and dopamine agonists.
    McCarty MF
    Med Hypotheses; 2001 Aug; 57(2):258-75. PubMed ID: 11461185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics.
    Schulz O; Hammerschmidt SI; Moschovakis GL; Förster R
    Annu Rev Immunol; 2016 May; 34():203-42. PubMed ID: 26907216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized multi-organ autoimmunity in CCR7-deficient mice.
    Davalos-Misslitz AC; Rieckenberg J; Willenzon S; Worbs T; Kremmer E; Bernhardt G; Förster R
    Eur J Immunol; 2007 Mar; 37(3):613-22. PubMed ID: 17304629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical potential of chemokine receptor antagonists.
    Ribeiro S; Horuk R
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
    Kikly K; Liu L; Na S; Sedgwick JD
    Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology. Autoreactive B cells migrate into T cell territory.
    Fu YX; Storb U
    Science; 2002 Sep; 297(5589):2006-8. PubMed ID: 12242429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.